Yousif Capital Management LLC Boosts Holdings in Haleon PLC Sponsored ADR $HLN

Yousif Capital Management LLC increased its holdings in Haleon PLC Sponsored ADR (NYSE:HLN) by 10.4% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,494 shares of the company’s stock after purchasing an additional 4,280 shares during the period. Yousif Capital Management LLC’s holdings in Haleon were worth $472,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Hanson & Doremus Investment Management lifted its holdings in Haleon by 234.1% in the 2nd quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company’s stock worth $25,000 after purchasing an additional 1,662 shares in the last quarter. Bartlett & CO. Wealth Management LLC increased its stake in Haleon by 135.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company’s stock worth $27,000 after acquiring an additional 1,491 shares during the last quarter. Banque Transatlantique SA bought a new stake in Haleon in the 1st quarter worth approximately $27,000. Ransom Advisory Ltd bought a new stake in Haleon in the 1st quarter worth approximately $31,000. Finally, Deutsche Bank AG increased its stake in Haleon by 267.8% in the 1st quarter. Deutsche Bank AG now owns 3,126 shares of the company’s stock worth $32,000 after acquiring an additional 2,276 shares during the last quarter. 6.67% of the stock is owned by hedge funds and other institutional investors.

Haleon Stock Performance

NYSE HLN opened at $9.35 on Friday. The company has a market cap of $41.62 billion, a P/E ratio of 23.96, a P/E/G ratio of 2.76 and a beta of 0.20. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.63 and a current ratio of 0.87. The business’s 50 day moving average price is $9.39 and its 200-day moving average price is $9.98. Haleon PLC Sponsored ADR has a fifty-two week low of $8.71 and a fifty-two week high of $11.42.

Haleon Increases Dividend

The firm also recently disclosed a semi-annual dividend, which was paid on Thursday, September 18th. Investors of record on Friday, August 15th were issued a dividend of $0.0555 per share. This represents a yield of 190.0%. The ex-dividend date was Friday, August 15th. This is an increase from Haleon’s previous semi-annual dividend of $0.05. Haleon’s dividend payout ratio (DPR) is presently 28.21%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on HLN shares. Barclays downgraded Haleon from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, September 16th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a research note on Wednesday, October 8th. Wall Street Zen downgraded Haleon from a “buy” rating to a “hold” rating in a research note on Saturday, July 12th. Finally, The Goldman Sachs Group raised Haleon from a “neutral” rating to a “buy” rating in a research note on Wednesday, September 10th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $12.33.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.